These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 25345427

  • 41. Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial.
    Edelman AB, Cherala G, Munar MY, McInnis M, Stanczyk FZ, Jensen JT.
    Contraception; 2014 Nov; 90(5):550-6. PubMed ID: 25070547
    [Abstract] [Full Text] [Related]

  • 42. Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    He YL, Sabo R, Riviere GJ, Sunkara G, Leon S, Ligueros-Saylan M, Rosenberg M, Dole WP, Howard D.
    Curr Med Res Opin; 2007 May; 23(5):1131-8. PubMed ID: 17519080
    [Abstract] [Full Text] [Related]

  • 43. Absence of an interaction between tigecycline and digoxin in healthy men.
    Zimmerman JJ, Harper DM, Matschke K, Speth JL, Raible DG, Fruncillo RJ.
    Pharmacotherapy; 2007 Jun; 27(6):835-44. PubMed ID: 17542766
    [Abstract] [Full Text] [Related]

  • 44. Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects.
    Moore KT, Byra W, Vaidyanathan S, Natarajan J, Ariyawansa J, Salih H, Turner KC.
    Br J Clin Pharmacol; 2015 Jun; 79(6):907-17. PubMed ID: 25475601
    [Abstract] [Full Text] [Related]

  • 45. Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.
    Johnson-Agbakwu C, Brown L, Yuan J, Kissling R, Greenblatt DJ.
    Clin Ther; 2018 Jan; 40(1):64-73. PubMed ID: 29198449
    [Abstract] [Full Text] [Related]

  • 46. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG, Dai Y.
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [Abstract] [Full Text] [Related]

  • 47. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
    Modi NB, Kell S, Simon M, Vargas R.
    J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
    [Abstract] [Full Text] [Related]

  • 48. Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers.
    Menon S, Riese R, Wang R, Alvey CW, Shi H, Petit W, Krishnaswami S.
    Clin Pharmacol Drug Dev; 2016 Sep; 5(5):336-42. PubMed ID: 27138968
    [Abstract] [Full Text] [Related]

  • 49. Lack of effect of multiple doses of vortioxetine on the pharmacokinetics and pharmacodynamics of aspirin and warfarin.
    Chen G, Zhang W, Serenko M.
    J Clin Pharmacol; 2015 Jun; 55(6):671-9. PubMed ID: 25641606
    [Abstract] [Full Text] [Related]

  • 50. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.
    Wright DH, Herman GA, Maes A, Liu Q, Johnson-Levonas AO, Wagner JA.
    J Clin Pharmacol; 2009 Oct; 49(10):1157-67. PubMed ID: 19783710
    [Abstract] [Full Text] [Related]

  • 51. Lack of a clinically important pharmacokinetic interaction between sofosbuvir or ledipasvir and hormonal oral contraceptives norgestimate/ethinyl estradiol in HCV-uninfected female subjects.
    German P, Moorehead L, Pang P, Vimal M, Mathias A.
    J Clin Pharmacol; 2014 Nov; 54(11):1290-8. PubMed ID: 24925712
    [Abstract] [Full Text] [Related]

  • 52. The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.
    Gu N, Kim BH, Lim KS, Kim SE, Nam WS, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS.
    Clin Ther; 2012 Jul; 34(7):1592-600. PubMed ID: 22727611
    [Abstract] [Full Text] [Related]

  • 53. Zibotentan Can Be Co-administered with Contraceptives Containing Ethinyl Estradiol and Levonorgestrel: A Pharmacokinetic Drug-Drug Interaction Study.
    Mercier AK, Kois AK, Karsanji D, Baldry R, Birve F, Hedwall M, Molodetskyi O, Gillen M.
    Clin Pharmacol Ther; 2024 Aug; 116(2):372-379. PubMed ID: 38686600
    [Abstract] [Full Text] [Related]

  • 54. Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects.
    Hausner H, Derving Karsbøl J, Holst AG, Jacobsen JB, Wagner FD, Golor G, Anderson TW.
    Clin Pharmacokinet; 2017 Nov; 56(11):1391-1401. PubMed ID: 28349387
    [Abstract] [Full Text] [Related]

  • 55. Single-dose Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Selective Inhibitor of Sodium Glucose Cotransporter 2, in Healthy Indian Participants.
    Devineni D, Polidori D, Curtin C, Stieltjes H, Tian H, Wajs E.
    Clin Ther; 2016 Jan 01; 38(1):89-98.e1. PubMed ID: 26687552
    [Abstract] [Full Text] [Related]

  • 56. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
    Simonson SG, Martin PD, Mitchell PD, Lasseter K, Gibson G, Schneck DW.
    J Clin Pharmacol; 2005 Aug 01; 45(8):927-34. PubMed ID: 16027403
    [Abstract] [Full Text] [Related]

  • 57. A comparison of the pharmacokinetic profile of an ascending-dose, extended-regimen combined oral contraceptive to those of other extended regimens.
    Darwish M, Bond M, Ricciotti N, Hsieh J, Fiedler-Kelly J, Grasela T.
    Reprod Sci; 2014 Nov 01; 21(11):1401-10. PubMed ID: 24647707
    [Abstract] [Full Text] [Related]

  • 58. Lack of pharmacokinetic interactions between dapagliflozin and simvastatin, valsartan, warfarin, or digoxin.
    Kasichayanula S, Chang M, Liu X, Shyu WC, Griffen SC, LaCreta FP, Boulton DW.
    Adv Ther; 2012 Feb 01; 29(2):163-77. PubMed ID: 22271159
    [Abstract] [Full Text] [Related]

  • 59. Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial.
    Stein P, Berg JK, Morrow L, Polidori D, Artis E, Rusch S, Vaccaro N, Devineni D.
    Metabolism; 2014 Oct 01; 63(10):1296-303. PubMed ID: 25110280
    [Abstract] [Full Text] [Related]

  • 60. Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.
    Friedrich C, Port A, Ring A, Graefe-Mody U, Giessmann T, Iovino M, Woerle HJ.
    Clin Drug Investig; 2011 Oct 01; 31(9):643-53. PubMed ID: 21714581
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.